Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today?
InvestorPlace - Stock Market News, Stock Advice & Trading Tips
Abeona Therapeutics stock is falling on Tuesday after the FDA sent it a CRL for more CMC data before it would approve Pz-cel.
The post Why Is Abeona Therapeutics (ABEO) Stock Down 45% Today? appeared first on InvestorPlace.
More From InvestorPlace- The #1 AI Investment Might Be This Company You’ve Never Heard Of
- Musk’s “Project Omega” May Be Set to Mint New Millionaires. Читать дальше...